1. Goodman LS, Wintrobe MM, Dameshek W. Goodman MJ, Gilman A, McLennan MT: Nitrogen mustard therapy: Use of methyl-bis (β-chloroethyl) amine hydrochloride and tris (β-chloroethyl) amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J AMA 132:126–132, 1946.
2. Rauscher FJ Jr: National Cancer Program. Report of the Director. DHEW Publication No. (NIH) 77–472, 1977.
3. Bodey GP, Hersh EM, Valdivieso M, Feld R, Rodriguez V: Effects of cytotoxic and immunosuppressive agents on the immune system. Postgrad Med 58:67–74, 1975.
4. Levine AS, Schimpff SC, Grow RG Jr, Young RC: Hematologic malignancies and other marrow failure states: Progress in the management of complicating infections. Semin Hematol 11:141–202, 1974.
5. Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340, 1966.